(58 days)
Not Found
No
The document mentions "auto analysis software" for "auto measurement and auto interpretation," which is a common feature in traditional ECG devices and does not necessarily imply AI/ML. There is no mention of AI, ML, deep learning, neural networks, or any related terms.
No
The device is described as an electrocardiograph for acquiring, analyzing, displaying, and recording ECG signals to help diagnose heart disease, rather than treating it.
Yes
The device is described as acquiring ECG signals to "help users to analyze and diagnose heart disease," and its intended use is for the "cardiogram recorded ... to help users to analyze and diagnose heart disease." This clearly indicates its role in the diagnostic process.
No
The device description explicitly mentions hardware components such as a signal acquisition module, central processing unit, LCD, thermal printer, and USB printer. It also details hardware testing in the performance studies summary.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the body. The intended use and device description clearly state that the ECG Series Electrocardiograph acquires ECG signals from the body surface through electrodes. This is a non-invasive measurement of electrical activity within the body, not an analysis of a biological sample (like blood, urine, or tissue) taken from the body.
- The device measures electrical signals, not biological markers. IVDs typically measure or detect specific biological substances or characteristics in a sample. This device measures electrical potentials generated by the heart.
Therefore, the ECG Series Electrocardiograph falls under the category of a medical device that performs physiological measurements, but it is not an IVD.
N/A
Intended Use / Indications for Use
The intended use of the ECG Series Electrocardiograph is to acquire ECG signals from adult and pediatric patients through the body surface ECG electrodes. The electrocardiograph is only intended to be used in hospitals or healthcare facilities by doctors and trained healthcare professionals. The cardiogram recorded by the electrocardiograph can help users to analyze and diagnose heart disease. However, the ECG with measurements and interpretative statements is offered to the clinician on an advisory basis only.
Product codes
DPS
Device Description
The ECG Series Electrocardiograph is designed to acquire, analyze, display and record ECG signals from the patient body surface by ECG electrodes. After being amplified, filtered and analyzed, the ECG signal waveforms and analysis results are displayed in the LCD and recorded in the paper through thermal printer or USB printer. ECG data, result and information of patient may be stored in the memory file. The file can be transmitted to a PC through UART or Ethernet interface. Also the device can be configured with the auto analysis software as optional which helps to carry out auto measurement and auto interpretation.
The ECG Series Electrocardiograph device consists of two basic components: the signal acquisition module and central processing unit. Models provide rechargeable battery.
The ECG series electrocardiograph can be divided into two types of devices: the ECG -12, ECG -12 Plus, and the ECG-3F Plus, ECG-3F, ECG-3 Plus and ECG-3 series.
The ECG-3F Plus, ECG-3F, ECG-3 Plus and ECG-3 series are three channel Electrocardiographs, which can print out three channel electrocardiograph waves simultaneously by an 80 mm wide thermal line printer. The different between and ECG-3F and ECG -3 is the shell.
ECG-12 and ECG-12 Plus series are twelve channel Electrocardiographs, and they can print out twelve channel electrocardiograph waves simultaneously by a 216mm wide thermal line printer. The difference between the ECG-12 and ECG-12 Plus is the shell.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
body surface
Indicated Patient Age Range
adult and pediatric patients
Intended User / Care Setting
doctors and trained healthcare professionals / hospitals or healthcare facilities
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Testing was conducted to validate and verify that the ECG Series Electrocardiograph met all design specifications and was substantially equivalent to the predicate devices. The following quality assurance measures were applied to the development of the ECG Series Electrocardiograph:
- . Software Testing
- ♥ Hardware Testing
- . Safety Testing
- . Electromagnetic Compatibility Testing
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2340 Electrocardiograph.
(a)
Identification. An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart.(b)
Classification. Class II (performance standards).
0
510(K) Summary
AUG 2 4 2011
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
The assigned 510(k) number is: 50 September is: 505
Submitter
Advanced Instrumentations, Inc. 6800 N.W. 77th Court Miami, Fl 33166 Telephone: 305-477-6331 Fax: 305-477-5351
Registration # 1066270
Official correspondent :
Jorge Millan, PhD Email: imillan@hiatec.org 601 West 20 St Hialeah, FL 33010 Phone : (305) 925-1260
Date Prepared:
June 22, 2011
Name of the device:
- Trade/Proprietary Name: ECG Series Electrocardiograph (models ECG-. 12 Plus, ECG-12, ECG-3F Plus, ECG-3F, ECG-3 Plus, ECG-3)
- Electrocardiograph . Common Name:
- . Classification:
21 CFR 870.2340 Regulation number: Regulation name: Electrocardiograph
1
Regulatory Class: Class II Product Code: DPS
Legally Marketed Predicate Device:
K091513 SE Series Electrocardiograph K014108 MAC 5000 ECG Analysis System
Device Description:
The ECG Series Electrocardiograph is designed to acquire, analyze, display and record ECG signals from the patient body surface by ECG electrodes. After being amplified, filtered and analyzed, the ECG signal waveforms and analysis results are displayed in the LCD and recorded in the paper through thermal printer or USB printer. ECG data, result and information of patient may be stored in the memory file. The file can be transmitted to a PC through UART or Ethernet interface. Also the device can be configured with the auto analysis software as optional which helps to carry out auto measurement and auto interpretation.
The ECG Series Electrocardiograph device consists of two basic components: the signal acquisition module and central processing unit. Models provide rechargeable battery.
The ECG series electrocardiograph can be divided into two types of devices: the ECG -12, ECG -12 Plus, and the ECG-3F Plus, ECG-3F, ECG-3 Plus and ECG-3 series.
The ECG-3F Plus, ECG-3F, ECG-3 Plus and ECG-3 series are three channel Electrocardiographs, which can print out three channel electrocardiograph waves simultaneously by an 80 mm wide thermal line printer. The different between and ECG-3F and ECG -3 is the shell.
ECG-12 and ECG-12 Plus series are twelve channel Electrocardiographs, and they can print out twelve channel electrocardiograph waves simultaneously by a 216mm wide thermal line printer. The difference between the ECG-12 and ECG-12 Plus is the shell.
Statement of Intended Use:
The intended use of the ECG Series Electrocardiograph is to acquire ECG signals from adult and pediatric patients through the body surface ECG electrodes. The electrocardiograph is only intended to be used in hospitals or healthcare facilities by doctors and trained healthcare professionals. The cardiogram recorded by the electrocardiograph can help users to analyze and
2
510{k) Summary ECG-12 Series
heart disease. However, the ECG with measurements and diagnose interpretative statements is offered to the clinician on an advisory basis only.
Contraindications
None known at this time
Technological Characteristics:
The technological characteristics of the ECG Series Electrocardiograph have been updated to reflect use of current technology and to incorporate userrequested features. Data in this submission demonstrates that these technological characteristics do not raise new questions of safety or effectiveness.
Test Summary:
Testing was conducted to validate and verify that the ECG Series Electrocardiograph met all design specifications and was substantially equivalent to the predicate devices. The following quality assurance measures were applied to the development of the ECG Series Electrocardiograph:
- . Software Testing
- ♥ Hardware Testing
- . Safety Testing
- . Electromagnetic Compatibility Testing
For more information, please see our declaration of conformity to harmonized standards (Exhibit 13).
Conclusion:
and validation testing was done on the ECG Verification -Series Electrocardiograph. This premarket notification submission demonstrates that the ECG Series Electrocardiograph is substantially equivalent to the cleared K091513 SE Series Electrocardiograph and K014108 MAC 5000 ECG Analysis System. The device we intent to market has the same intended use and technological characteristics as the K091513 SE Series Electrocardiograph, and therefore does not raise new questions of safety or effectiveness.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the perimeter. Inside the circle is an abstract image of an eagle or other bird-like figure, with stylized wings and tail feathers.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Advanced Instrumentations, Inc. c/o Dr. Jorge Millan Hialeah Technology Center 601 West 20 St. Hialeah, FL 33010
AUG 2 4 2011
Re: K111805
Trade/Device Name: ECG Series Electrocardiograph (models ECG 12 Plus, ECG 12, ECG 3F Plus, ECG 3F, ECG 3 Plus, and ECG 3) Regulation Number: 21 CFR 870.2340 Regulation Name: Electrocardiograph Regulatory Class: Class II (two) Product Code: DPS Dated: August 4, 2011 Received: August 9, 2011
Dear Dr. Millan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading,
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Dr. Jorge Millan
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements and united to: registration and Intist
CFR Part 807); lebeling (21 CER D- 4 901); . . . . . . . . . . . . . . . . . . . . . . . . . . . CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 100-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRH0ffices/ucm1 15809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbanding by reference to premarket notification" (21CFR Part 807.97). For questions regarding of reference to premation (21CFR Part
807.97). For questions the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll the Act Irom the (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices
Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number: K111805
ECG Series Electrocardiograph (models ECG-12 Plus, ECG-Device Name: 12, ECG-3F Plus, ECG-3F, ECG-3 Plus, ECG-3)
Indications For Use:
The intended use of the ECG Series Electrocardiograph is to acquire ECG signals from adult and pediatric patients through the body surface ECG electrodes. The electrocardiograph is only intended to be used in hospitals or healthcare facilities by doctors and trained healthcare professionals. The cardiogram recorded by the electrocardiograph can help users to analyze and diagnose heart disease. However, the ECG with measurements and interpretative statements is offered to the clinician on an advisory basis only.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH Office of Device Evaluation (ODE)
ﺎ ﻓﻲ ﺍﻟﻤﺮﻛﺰ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍ
(Division Sign-Off)
Division of Cardiovascular Devices
510(k) Number K111805
Page 1 of __ 1 __